Ann: Voluntary Suspension, page-59

The 28.9M MRFF grant was allocated to ALHI not solely 4DX, ALHI's goal "the development of the world’s first dedicated lung function scanners, with a vision towards zero dose". 4DX is a considerable partner in the Initiative but the grant was not targeted at aiding the commercialization of the XV algorithm. MRFF granted ALHI $1.1M in stage one, which was used to " successfully delivered a Generation One concept scanner – a walk-through device that is intended to showcase XVD Scanner’s suitability for adults and children as young as three."

So as we can see not only did they successfully deliver a concept scanner through stage 1, they've been further granted another $28.9M to commercialize the scanner through stages 2 and 3. The scanner is meant to aid higher risk patients who would benefit from a low as possible radiation dosage as well as increase accessibility for patients with disabilities.

Do you seriously think the management team didn't understand the short-term repercussions of raising capital now? I'm sure they're not a bunch of knuckle heads who decided to go public on some idea they came up with stoned one night. It seems if anything they are confident with the scanners and they want to enter production, raising another $40M will aid the roll out process. Yes it is annoying they didn't CP at a $2+SP but if you're a long term holder who believes in the company it is simply a small hit.

This doesn't mean that any of the existing plans/timelines with the XV algorithm are suddenly not going to plan. Why wouldn't 4DX open as many possible revenue streams as they can? We can all speculate till the cows come home but waste your time doing something useful. An announcement will come soon enough regarding the capital raise, then we can all cry.